Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2025-12-25 @ 2:54 PM
NCT ID:
NCT03098550
Group ID:
EG002
Title:
Nivolumab + Daratumumab (PAC)
Description:
Pancreatic adenocarcinoma cancer (PAC) treated with Nivolumab IV 240 mg Q2W (weeks 3 to 24) + Daratumumab IV 16 mg/kg Q1W (weeks 1 to 8), Daratumumab IV 16 mg/kg Q2W (weeks 9-24)
Deaths Number Affected:
36
Deaths Number At Risk:
None
Serious Number Affected:
36
Serious Number At Risk:
43
Other Number Affected:
41
Other Number At Risk:
43
Study:
NCT03098550
Results Section:
NCT03098550
Adverse Events Module:
NCT03098550